| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CARCIN/18.3.517 |
| P698 | PubMed publication ID | 9067551 |
| P2093 | author name string | Rao DR | |
| Chawan CB | |||
| Challa A | |||
| Shackelford L | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | β-lactulose | Q422689 |
| Bifidobacterium longum | Q4904768 | ||
| P304 | page(s) | 517-521 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. | |
| P478 | volume | 18 |
| Q33860298 | A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds |
| Q38143713 | A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action |
| Q43148199 | Cancer-preventing attributes of probiotics: an update |
| Q44197112 | Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment. |
| Q34820603 | Diet and cancer: assessing the risk |
| Q35161393 | Dietary fibre: a roughage guide |
| Q27012682 | Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches |
| Q43564045 | Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism |
| Q33438678 | Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers |
| Q33622636 | Functional foods and their role in cancer prevention and health promotion: a comprehensive review |
| Q34881370 | Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome |
| Q35195785 | Gut microbiota, immunity, and disease: a complex relationship |
| Q35900047 | Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats |
| Q74505877 | Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane |
| Q34820566 | Lactic acid bacteria and cancer: mechanistic perspective |
| Q33431282 | Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. |
| Q27012999 | Mechanisms and therapeutic effectiveness of lactobacilli |
| Q27027582 | Microbiome, inflammation, and cancer |
| Q24650990 | Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency |
| Q89209482 | Nutraceuticals in colorectal cancer: A mechanistic approach |
| Q44502414 | Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions |
| Q34485634 | Potential role of probiotics on colorectal cancer prevention |
| Q24681377 | Potential uses of probiotics in clinical practice |
| Q34141652 | Prebiotic effects: metabolic and health benefits |
| Q34542171 | Probiotics and colon cancer |
| Q24524299 | Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? |
| Q81885279 | Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? |
| Q36720519 | Probiotics and the incidence of colorectal cancer: when evidence is not evident. |
| Q34637436 | Probiotics in the gastrointestinal diseases of the elderly. |
| Q33223485 | Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits |
| Q37333713 | Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer |
| Q39414117 | Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk |
| Q92443531 | Synbiotic Combination of Djulis (Chenopodium formosanum) and Lactobacillus acidophilus Inhibits Colon Carcinogenesis in Rats |
| Q35571641 | The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition |
| Q37174716 | The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? |
| Q33960396 | The role of probiotic bacteria in cancer prevention |
Search more.